Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Feb;57(2):1104-5.
doi: 10.1128/AAC.02216-12.

Reply to "Contradictory results with high-dosage rifamycin in mice and humans"

Eric L Nuermberger, Ian M Rosenthal, Rokeya Tasneen, Charles A Peloquin, Khisimuzi E Mdluli, Petros C Karakousis, Jacques H Grosset
Comment

Reply to "Contradictory results with high-dosage rifamycin in mice and humans"

Eric L Nuermberger et al. Antimicrob Agents Chemother. 2013 Feb.
No abstract available

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Coates ARM, Hu Y, Jindani A, Mitchison DA. 2012. Contradictory results with high-dosage rifamycin in mice and humans. Antimicrob. Agent Chemother. 57:1103 - PMC - PubMed
    1. Rosenthal IM, Tasneen R, Peloquin CA, Zhang M, Almeida D, Mdluli KE, Karakousis PC, Grosset JH, Nuermberger EL. 2012. Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis. Antimicrob. Agents Chemother. 56:4331–4340 - PMC - PubMed
    1. Dorman SE, Goldberg S, Stout JE, Muzanyi G, Johnson JL, Weiner M, Bozeman L, Heilig CM, Feng PJ, Moro R, Narita M, Nahid P, Ray S, Bates E, Haile B, Nuermberger EL, Vernon A, Schluger NW, Tuberculosis Trials Consortium 2012. Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the Tuberculosis Trials Consortium. J. Infect. Dis. 206:1030–1040 - PubMed
    1. Mitchison DA. 2012. Pharmacokinetic/pharmacodynamic parameters and the choice of high-dosage rifamycins. Int. J. Tuberc. Lung Dis. 16:1186–1189 - PubMed
    1. Jayaram R, Gaonkar S, Kaur P, Suresh BL, Mahesh BN, Jayashree R, Nandi V, Bharat S, Shandil RK, Kantharaj E, Balasubramanian V. 2003. Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis. Antimicrob. Agents Chemother. 47:2118–2124 - PMC - PubMed

MeSH terms

LinkOut - more resources